Literature DB >> 17409788

Brainstem tumors: where are we today?

Pablo F Recinos1, Daniel M Sciubba, George I Jallo.   

Abstract

Brainstem tumors comprise 10-20% of all pediatric central nervous system tumors. The management of these tumors has evolved dramatically in the past century. Once considered uniformly fatal, it is now known that brainstem tumors have distinguishing characteristics and do not behave identically. The focality and location of the lesion is determined from the clinical history, presentation, and associated imaging. Based on these findings, it is possible to predict the behavior of the tumor and choose an appropriate intervention. Focal lesions have a good prognosis and are treated operatively while diffuse lesions have a poor prognosis and are managed medically. This article reviews the current classification of brainstem tumors, current management options and future directions for the treatment of these rare tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17409788     DOI: 10.1159/000098831

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  23 in total

Review 1.  Intraoperative neurophysiology in posterior fossa tumor surgery in children.

Authors:  Francesco Sala; Angela Coppola; Vincenzo Tramontano
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

2.  Efficacy of vincristine administered via convection-enhanced delivery in a rodent brainstem tumor model documented by bioluminescence imaging.

Authors:  Guifa Xi; Veena Rajaram; Babara Mania-Farnell; Chandra S Mayanil; Marcelo B Soares; Tadanori Tomita; Stewart Goldman
Journal:  Childs Nerv Syst       Date:  2012-01-27       Impact factor: 1.475

3.  Intrinsic brainstem glioma mimicking an ependymoma.

Authors:  Manish K Kasliwal; Deepak Agrawal
Journal:  Pediatr Radiol       Date:  2009-05-13

Review 4.  Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.

Authors:  Adam L Green; Mark W Kieran
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

5.  Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.

Authors:  Gordon Li; Siddhartha S Mitra; Michelle Monje; Kristy N Henrich; C Dana Bangs; Ryan T Nitta; Albert J Wong
Journal:  J Neurooncol       Date:  2012-03-02       Impact factor: 4.130

6.  Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study.

Authors:  U W Thomale; B Tyler; V M Renard; B Dorfman; M Guarnieri; H E Haberl; G I Jallo
Journal:  Childs Nerv Syst       Date:  2008-08-09       Impact factor: 1.475

7.  Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience.

Authors:  Paul Klimo; Atmaram S Pai Panandiker; Clinton J Thompson; Frederick A Boop; Ibrahim Qaddoumi; Amar Gajjar; Gregory T Armstrong; David W Ellison; Larry E Kun; Robert J Ogg; Robert A Sanford
Journal:  J Neurosurg Pediatr       Date:  2013-01-04       Impact factor: 2.375

8.  Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.

Authors:  Rintaro Hashizume; Ivan Smirnov; Sharon Liu; Joanna J Phillips; Jeanette Hyer; Tracy R McKnight; Michael Wendland; Michael Prados; Anu Banerjee; Theodore Nicolaides; Sabine Mueller; Charles D James; Nalin Gupta
Journal:  J Neurooncol       Date:  2012-09-17       Impact factor: 4.130

9.  Brainstem glioma progression in juvenile and adult rats.

Authors:  Qing Liu; Ran Liu; Meghana V Kashyap; Rajnee Agarwal; Xiang'en Shi; Chung-cheng Wang; Shao-Hua Yang
Journal:  J Neurosurg       Date:  2008-11       Impact factor: 5.115

10.  A human brainstem glioma xenograft model enabled for bioluminescence imaging.

Authors:  Rintaro Hashizume; Tomoko Ozawa; Eduard B Dinca; Anuradha Banerjee; Michael D Prados; Charles D James; Nalin Gupta
Journal:  J Neurooncol       Date:  2009-07-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.